semaglutide and kidney problems Semaglutides Are Poised to Remake Chronic Disease Care Long-term kidney outcomes of semaglutide

Available online at: (Accessed June 17, 2025)

When used in conjunction with diet and exercise, it can cause significant weight loss and a reduced risk of cancer, diabetes and heart disease in people who are fat or over-weight

FDA maintains ongoing safety surveillance on over-the-counter products and can require labeling changes

Nutritional deficiencies: Changes in appetite, nausea, or rapid weight loss can lead to low levels of calcium, vitamin D, and other nutrients that support strong teeth and bones

Ozempic and Wegovy are brand names for semaglutide

BPC-157 is most associated in animal studies with new blood vessel formation and tissue protection at the injury site